Indeed, in MM patients, serum/plasma NGAL levels share a relationship with M protein levels, international staging system (ISS) stage, and disease status, indicating utility as a bimodal marker of tumor burden and renal injury [50,52,53]. Here, LCN2 is linked to Miyoshi myopathy.